![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetics of Temsavir, the Active Moiety of the Prodrug Fostemsavir, in Subjects with Hepatic Impairment
 
|
|
|
Reported by Jules Levin
IDWeek 2017™; October 4-8, 2017; San Diego, CA  
K Moore,1M Magee,2P Ackerman,3H Sevinsky,4R Adamczyk,5J Karkas,6S Lubin,5P Ravindran,6T Eley,6C Llamoso3
1ViiV Healthcare, Research Triangle Park, NC; 2GlaxoSmithKline, Upper Merion, PA; 3ViiV Healthcare, Wallingford, CT; 4ViiV Healthcare, Upper Providence, PA; 5Bristol-Myers Squibb, Hopewell, NJ; 6Bristol Myers Squibb, Lawrenceville, NJ
![1026171](../images/102717/102717-5/1026171.gif)
![1026172](../images/102717/102717-5/1026172.gif)
![1026173](../images/102717/102717-5/1026173.gif)
![1026174](../images/102717/102717-5/1026174.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|